The Court for Arbitration for Sport has increased Italian tennis ace Sara Errani's suspension from two to ten months for an anti-doping violation which has left the player frustrated. Errani was tested positive for letrozole in an out of competition test in February, earlier last year.
Errani was tested positive for taking letrozole at her family home in an out of competition drug test in February 2017. However, while the consumption of the banned substance resulted in the announcement of her suspension in April 2017, she had appealed that her test
The substance, used in the treatment of breast cancer, has been accepted by CAS as the medication taken by her mother that eventually was detected in the food prepared by the player's mother and consumed by the entire family. The Italian anti-doping agency had asked for a longer ban for Errani but the CAS finding Errani to be guilty of a light degree of
“I am really disgusted by this matter. I don't think anything similar has ever happened or managed- in my humble opinion- in such a shameful manner,” Errani stated in her official Twitter account.
“I have already served seven months, between results disqualification and period of inactivity. I have been forced to restart with
The decision has left Sara Errani doubtful of the fact that if she would be back for playing further in tennis.
“I find, in all this matter, a very unfair treatment….I don't know if I will be able to find the strength and the desire to play tennis again, after all this,” Errani said.